GGrantIndex
Sort

46,585 grants matching heart failure

MPO, HDL Dysfunction and Cardiovascular Disease

$716,838
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2016 · HL

The Race-Specific Prevalence of Atrial Fibrillation Measured by 48-Hour Holter

$716,819
Laura L Loehr · Univ Of North Carolina Chapel Hill · R01 · FY2014 · HL

Missense Variants in Myosin Binding Protein C that Cause Hypertrophic Cardiomyopathy

$716,788
Sharlene M Day · University Of Pennsylvania · R01 · FY2023 · HL

The NKA Interactome in Health and Disease

$716,787
Seth L Robia · Loyola University Chicago · R01 · FY2022 · HL

Deciphering the role of a circadian lncRNA in cardiac remodeling

$716,778
Lilei Zhang · Baylor College Of Medicine · R01 · FY2022 · HL

Multi-omic markers of cardiac function and structure within the pressure overloaded heart

$716,764
Sammy Elmariah · University Of California, San Francisco · R01 · FY2024 · HL

Role of The Rho-GAP GRAF3 In The Pathogenesis of Human Hypertension

$716,732
Joan M. Taylor · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL

Cardiovascular Risk Prediction and Reduction in Men with Prostate Cancer

$716,697
Bonnie Ky · University Of Pennsylvania · R01 · FY2025 · HL

The Race-Specific Prevalence of Atrial Fibrillation Measured by 48-Hour Holter

$716,697
Laura L Loehr · Univ Of North Carolina Chapel Hill · R01 · FY2015 · HL

Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)

$716,632
Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2019 · HL

Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients

$716,603
Majid Afshar · University Of Wisconsin-Madison · R01 · FY2023 · DA

Ultrasound-guided, Robotically Steerable Guidewire for Endovascular Interventions

$716,587
Jaydev P. Desai · Georgia Institute Of Technology · R01 · FY2020 · HL

COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.

$716,579
John A Dodson · New York University School Of Medicine · R01 · FY2022 · AG

BLOOD PRESSURE CONTROL IN HYPERTENSIVE SMOKERS

$716,577
Mayo Clinic · R01 · FY2004 · HL

Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArT–HS)

$716,551
Gregory A Jicha · University Of Kentucky · R01 · FY2022 · AG

Deep learning on ECGs to improve outcomes in patients on dialysis

$716,516
Girish Nitin Nadkarni · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL

Improving Blood Pressure & Vascular risk with resistance exercise in African Americans

$716,445
Shane A Phillips · University Of Illinois At Chicago · R01 · FY2017 · HL

Advanced Heart Failure: Epidemiology and Outcomes

$716,429
Shannon Marie Dunlay · Mayo Clinic Rochester · R01 · FY2023 · HL

Photoabsorbing bioinks for expanding 3D printed human liver in situ

$716,386
Kelly R Stevens · University Of Washington · R01 · FY2023 · DK

Murine cardiac vector-flow imaging with high-frequency 2D row-column CMUT arrays

$716,383
Jeffrey Ketterling · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL

Longitudinal study of determinants of medication adherence in COPD

$716,353
Michelle Nuttall Eakin · Johns Hopkins University · R01 · FY2018 · HL

Defining the lymphatic basis of protein losing enteropathy after Fontan palliation or inflammatory gut disease

$716,331
Gwendalyn J Randolph · Washington University · DP1 · FY2024 · DK

Sleep and Blood Pressure-Related Endothelial Abnormalities

$716,304
Christopher A Desouza · University Of Colorado · R01 · FY2020 · HL

Neural response to inflammatory challenge in major depressive disorder

$716,247
Jonathan Savitz · Laureate Institute For Brain Research · R01 · FY2024 · MH

UFRCC for Cardiovascular Cell Therapy Research Network

$716,162
Carl J Pepine · University Of Florida · UM1 · FY2013 · HL